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ImprintingThe zinc ﬁnger transcription factor Zac1 is expressed in dividing progenitors of the nervous system with
expression levels negatively controlled by genomic imprinting. To explore the consequences of elevated ZAC1
levels during neurogenesiswe overexpressed it in the developing CNS. Increased levels of ZAC1 rapidly promoted
upregulation of CDK inhibitors P57 and P27 followed by cell cycle exit. Surprisingly this was accompanied by
stalled neuronal differentiation. Genome wide expression analysis of cortical cells overexpressing Zac1 revealed
a decrease in neuronal gene expression and an increased expression of imprinted genes, factors regulating
mesoderm formation as well as features of differentiated muscle. In addition, we observed a rapid induction of
several genes regulating pluripotency. Taken together, our data suggests that expression levels of Zac1 need to
be kept under strict control to avoid premature cell cycle exit, disrupted neurogenesis and aberrant expression
of non-neuronal genes including pluripotency associated factors.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The generation of an organ requires strict control of the number and
identity of cells generated during development. Zac1 (also known as
Plagl1) belongs to an imprinted gene network (IGN), which has been
shown to control embryonic growth (Varrault et al., 2006). Accordingly,
Zac1 knockout mice exhibit reduced body size (Varrault et al., 2006).
ZAC1 has also been shown to induce apoptosis and cell cycle arrest
(Spengler et al., 1997). The ZAC1 gene is located at human chromosome
6q24, a locus that harbors a region which exhibits maternal allele
methylation in several types of tissue (Abdollahi, 2007). Loss of methyl-
ation results in loss of imprinting (LOI) and biallelic expression with
higher overall levels of the ZAC1 transcript. One consequence of ZAC1
LOI is disturbed pancreas islet development and transient neonatal
diabetes mellitus syndrome (Ma et al., 2004; Temple & Shield, 2002).
During central nervous system (CNS) development, neurons, astro-
cytes and oligodendrocytes are sequentially generated from a pool of
progenitors located in the neuroepithelium lining the ventricles. Zac1
is expressed in this germinal zone during development (Valente et al.,
2005) and a recent study shows that ZAC1 is necessary for proper neu-
ronalmigration in the developing cortex (Adnani et al., 2015). However,
the role for ZAC1 during neurogenesis is not fully understood. Our data
reveal that Zac1 expression in neuronal progenitors is regulated by the
SOXB1 (SOX1-3) family of transcription factors and that overexpression
of Zac1 promotes cell cycle exit through induction of the CDK inhibitorsg).
. This is an open access article under(CKIs) P57 in brain and P27 in spinal cord. This is accompanied by a fail-
ure to express key neuronal differentiation genes and stalled neuronal
differentiation. Genome wide expression data from developing cortices
show that ZAC1 regulates a cohort of imprinted genes in forebrain neu-
ral progenitors. In addition, there is a rapid induction of genes involved
inmesodermal speciﬁcation andmyogenic differentiation. Recent stud-
ies have shown that certain cell fate determinants can substitute for
core pluripotency factors during the generation of induced pluripotent
stem cells (iPSCs) (Takahashi et al., 2014; Shu et al., 2013; Montserrat
et al., 2013). Our analysis reveals that ZAC1 induced expression ofmeso-
dermal lineage determinants is also accompanied by expression of iPSC
associated genes.
Taken together, we demonstrate that it is essential to control Zac1
expression levels in neural progenitors in order to avoid premature
cell cycle exit, failed neuronal differentiation and aberrant activation
of determinants of non-neuronal lineages that provoke a rapid process
containing features of reprogramming.
2. Experimental procedures
2.1. Cell culture and transfection
293FT cells were seeded out in 9 wells of a 24 well plates at a
conﬂuence of 50,000 cells/well. After 24 h, 3 wells were Lipofectamine
transfected (LF 2000) with 100 ng of pCAGG-Zac1 together with
100 ng of P57Luc (Alheim et al., 2003) and 100 ng of a β-galactosidase
encoding vector. As control, 3 wells were Lipofectamine transfected
with 100 ng of pCAGG empty vector together with 100 ng of P57Lucthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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were not Lipofectamine transfected in order to serve as a control for
the luciferase assay. Following transfection, cells were grown for 24 h
and then growth media was removed from the cells. 150 μl of cell lysis
buffer (10 mM Tris–HCl pH 8.0, 1 mM EDTA pH 8.0, 150 mM NaCl,
0.65% NP-40, 0.4 mM PMSF, 1 mMDTT) was added and cells were incu-
bated for 20 min at 4 °C.2.2. β-Galactosidase assay
β-Galactosidase solution (60 mM Na2HPO4, 10 mM KCl, 1 mM
MgCl2, 40 mM NaH2PO4) with β-mercaptoethanol (3.5 μl/ml) and
ONPG (0.0025 g/ml) was added to 50 μl of each sample (lysed cells).
When samples turned yellow, stop solution was added (1 M Na2CO3).
Samples were analyzed using spectrophotometry at 405 nm to assess
the transfection efﬁciency.2.3. Luciferase assay
100 μl of luciferase buffer (H2O, 1MMgCl2, 1MKH2PO4 pH7.8, 0.1M
ATP) were added to each sample (lysed cells). Samples were inserted in
a luminometer together with a luciferin working solution (H2O, 1 M
KH2PO4 pH 7.8, 0.01 luciferin) that was automatically added to each
sample by the machine. Sample luminescence was measured to assess
expression of P57luc upon Zac1 overexpression.2.4. Zac1 electroporation inmouse cortex (in utero) and in chick spinal cord
(in ovo)
cDNA encoding mouse Zac1 was C-terminally fused to a Myc tag
and subcloned into a CMV based pCAGGS vector. The shCdkn1c vec-
tor was a Mission shRNA obtained from Sigma-Aldrich
(TRCN0000042590). E14.5 pregnant CD1 mice were anesthetized
with isoﬂurane and uterine horns were surgically exposed. 1–2 μl
of plasmids (8 μg/μl) in PBS with fast green (2 mg/ml; Sigma) was
injected using pulled glass microcapillaries into the lateral ventricle
of the embryos. For each embryo, ﬁve electric pulses of 50 V for
50 ms were discharged at intervals of 950 ms across the head using
an electroporator (Nepagene CUY21D) and platinum electrodes
(Nepagene CUY650P5). Pups were sacriﬁced at two different time
points: after 24 h and after 48 h. 2 h before sacriﬁcing the embryos,
BrdU (50 mg/kg) solution in PBS was injected. Heads were collected
in cold PBS. After dissection, brains were stored in 4% paraformalde-
hyde (PFA) overnight at 4 °C and consequently transferred in 30% su-
crose at 4 °C overnight. Brains were then cryosectioned (12 μm
thickness) onto Superfrost Plus slides (Thermo Scientiﬁc) for immu-
nohistochemistry analysis. For the pCAGG-Zac1/shCdkn1c in utero
electroporations, E14.5 cortices were injected with pCAGG-Zac1 (2
μg/μl) together with shCdkn1c (2 μg/μl). Fertilized chicken eggs
were incubated at 38 °C for 41–43 h to reach stage HH11. Albumen
(5 ml) was withdrawn with a syringe and the top of the shell was
opened in order to expose the embryo. The construct of interest
(1 μg/μl in PBS; 1 mM MgCl2; fast green) was injected in the neural
tube using pulled glass microcapillaries. 5 Electric pulses of 21 V for
50 ms each were discharged at intervals of 1 s. The opening of the
eggs was then taped in order to avoid the embryos to dry. Eggs
were incubated at 38 °C for 24 h. An hour before sacriﬁcing chick em-
bryos, BrdU (50 μM) solution in PBS was injected underneath the
embryos. After dissection, neural tubes were incubated in 4% para-
formaldehyde (PFA) for 2 h. After washing with PBS, neural tubes
were transferred in 30% sucrose solution overnight and then
cryosectioned (10 μm) onto Superfrost Plus slides (Thermo Scientif-
ic) where immunohistochemistry was performed.2.5. Immunohistochemistry
Cryosections were permeabilized with blocking solution (5% FBS,
0.2% Tween, PBS) for an hour at room temperature. Stainings were per-
formed with the following primary antibody incubated overnight at
4 °C: rbZAC1 (aliquot generously donated by L. Journot; 1:500), gtZAC1
(sc17854 Santa Cruz; 1:100), rbMYC (A-14, sc789, Santa Cruz; 1:500),
gtGFP (ab6673 Abcam; 1:100), rbSOX2 (AB5603 Millipore; 1:1000),
rbKI67 (ab16667 Abcam; 1:500), rbTBR2 (ab23345 Abcam; 1:500),
ratBrdU (Abcam; 1:250), mTUJ1 (MMS435P Covance 1:1000), rbP57
(Santa Cruz; 1:100), P27 (1:1000); mPH3 (05-806 Millipore 1:1000),
rbDESMIN (ab15200 Abcam 1:250). Secondary antibody Alexa Fluor
488 (1:500) was added for an hour at room temperature to detect
ZAC1 overexpression and GFP (control vector) expression. Secondary
antibody Alexa Fluor 555 (1:1000) was added for an hour at room tem-
perature to detect the other antibodies. When double staining with an-
other rabbit antibody, the rbMYC antibody was substituted with the
gtZAC1 antibody that only detects overexpressed ZAC1 and fails to
stain endogenous ZAC1 protein. There was a total and exclusive overlap
between gtZAC1 and rbMYC staining in pCAGG-Zac1-Myc electroporated
brains. To distinguish between endogenous ZAC1 immunodetection and
detection of overexpression we have added (gt) in the panels showing
Zac1 overexpression detected by the gtZAC1 antibody.2.6. Cell cycle labeling index (LI) calculation
Pregnant females undergoing in utero electroporation were exposed
to a single pulse label of BrdU at E14.5. 24 h after pulse label the embryos
were retrieved according to the procedure described above. Cryosections
of electroporated corticeswere stained for BrdU andKI67. The proportion
of electroporated cells that were BrdU+/KI67+ was divided by the total
number of electroporated BrdU+ cells (BrdU+/KI67+ + BrdU+/KI67−).
This LI represents the population of cells in S-phase at E14.5 that still
are KI67+ (i.e. in cell cycle) at E15.5.2.7. Alkaline phosphatase activity assay
Cryosections were washed in a 0.1 M Tris–Cl, pH 9.5, 0.1 M NaCl,
50 mMMgCl2 solution. They were then incubated at room temperature
in the same solution with BCIP/NBT (Roche) added according to
manufacturer's protocol. After staining the sections were washed in
PBS and coverslipped.2.8. RNA sequencing
24 h after overexpression of Zac1 (5 μg/μl) in mouse cortices via in
utero electroporation together with a GFP construct (5 μg/μl) or GFP
only as control (5 μg/μl), embryos were sacriﬁced and brains isolated.
A papain neural dissociation tissue kit (Miltenyi Biotech) was used to
dissociate brains (Zac1 n = 3, GFP only n = 4) into single cells. Cells
were then sorted for GFP with BD FACSAria II and GFP+ cells were
collected in RLT buffer (+β-mercaptoethanol). RNA extraction was
performed using RNeasy Micro Kit (Qiagen). The extracted RNA was
then used to make cDNA using SuperScript II Reverse Transcriptase
(Life Technologies). RNA Sequencing was performed following the
Smart-seq2 protocol (Picelli et al., 2014). Tagmentation was per-
formed using Nextera XT DNA Sample Preparation Kit (Illumina).
The samples were sequenced using HiSeq2000 Illumina DNA
Sequencing Instrument. Reads were mapped to the mouse genome
(mm10 assembly) using STAR (Dobin et al., 2013) and gene expres-
sion was calculated using RPKM for genes (Ramskold et al., 2009).
Differential gene expression was computed using DESeq2 (Love
et al., 2014).
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For analysis of Neuro2a cells, total RNA was extracted using RNeasy
microkit (Qiagen cat# 74004) and quantiﬁed on a Nanodrop 1000 de-
vice. 200 ng of RNA was used for generation of cDNA using Superscript
II (Invitrogen cat# 18064-22). To conﬁrm gene expression changes in
electroporated brains as obtained by RNA-seq, ampliﬁed cDNA from
individual libraries were analyzed. Expression levels of individual tran-
scripts were measured by qPCR on a ViiA™ 7 Real-Time PCR System
using Platinum SYBR Green qPCR super mix (Invitrogen cat# 11744)
using the following primers:
Alpl FW: ccaactcttttgtgccagaga RE: ggctacattggtgttgagctttt,
Des FW: gtggatgcagccactctagc RE: ttagccgcgatggtctcatac,
Tbx6 FW: atgtaccatccacgagagttgt RE: ggtagcggtaaccctctgtc,
Ccnf FW: gaaggactttacaagcctgtgt RE: ccagggcggaaatgatctcc,
Neurod1 FW: atgaccaaatcatacagcgagag RE: tctgcctcgtgttcctcgt,
Neurod6 FW: acgactggaaagggtcaagtt RE: gaccacttttcgcaaattgtcc,
Tubb3 FW: tagaccccagcggcaactat RE: gttccaggttccaagtccacc,
Cdkn1c FW: cgaggagcaggacgagaatc RE: gaagaagtcgttcgcattggc,
Igf2 FW: gtgctgcatcgctgcttac RE: acgtccctctcggacttgg,
Plagl1 FW: atggctccattccgctgtc RE: ctcagccttcgagcacttgaa,
Map 2 FW: ttggtgccgagtgagaaga RE: gtctggcagtggttggttaa,
Atp5j FW: tattggcccagagtatcagca RE: ggggtttgtcgatgacttcaaat,




For the comparison between the levels of Zac1 and Sox2 expression
in the 96 single cell RNA-seq data set (Hagey & Muhr, 2014) the
RPKMs were normalized to the average level of each gene with the
mean value set to 1. Outlier analysis through the GraphPad software
(Grubbs' test) identiﬁed one cell as an outlier; this cell was removed
from further analysis. The remaining 95 cells were divided into bins ac-
cording to Sox2 RPKMs. F-test followed by student's t-test was per-
formed within each bin to calculate if the difference between the
normalized levels of Sox2 and Zac1 transcripts was signiﬁcant. For
the qPCR analysis, expression levels were normalized to the geometric
means of three housekeeping genes (Ywhaz, L19, Atp5j). To calculate
increase or decrease in expression the Zac1-Myc transfected/
electroporated samples were normalized to the average of the eGFP
control samples. To calculate the signiﬁcance of the enrichment of
upregulated genes in the Zac1-Myc overexpressing cells also present
in the OSKM group derived from (Maekawa et al., 2011) we performed
a Chi-squared test. Chi-squared value p-value was calculated using a
Chi-Square Test calculator (Soper, 2015). For signiﬁcance calculations
of electroporated cells we performed f-test followed by two-tailed
student's t-test.
3. Results
3.1. ZAC1 is expressed in proliferating progenitors along the anterio-posterior
axis of the developing neural tube
To acquire a detailed view of ZAC1 expressionwe performed immu-
noﬂuorescent staining of the developing CNS at E10.5 and E14.5with an
antibody speciﬁc for ZAC1 togetherwithmarkers for neural progenitors,
proliferation and differentiation (Fig. 1A–F, S1 A–C). In the E10.5 neo-
cortex, ZAC1 is expressed in cycling progenitors of the ventricular
zone (VZ) whereas the small population of TUJ1+ neurons in the
preplate does not express ZAC1 (S1 A–C). In E10.5 spinal cord, ZAC1 is
expressed in cycling SOX3+ progenitors while differentiated TUJ1+
neurons in the marginal zone do not express ZAC1 (Fig. 1A–C). AtE14.5 a similar pattern is evident in the neocortex with ZAC1 immuno-
reactivity conﬁned to BrdU+ proliferating SOX3+ progenitors (Fig. 1D–
E) that do not express TUJ1 (Fig. 1F). Thus in the developing CNS ZAC1
expression is predominantly conﬁned to proliferating progenitors
both in forebrain and spinal cord.
3.2. Overexpression of Zac1 promotes premature cell cycle exit and
obstructs neuronal differentiation in spinal cord and cortex
To examine the consequences of increased Zac1 levels in the
developing CNS we overexpressed it in the developing chick spinal
cord, a well-studied model of neurogenesis. Notably, 24 h after electro-
poration, cells overexpressing Zac1 failed to incorporate BrdU implying
that high levels of ZAC1 promote cell cycle exit (S1 D). Electroporated
cells were located in the marginal zone and displayed downregulated
expression of the neural stem cell speciﬁc SOXB1 transcription factor
SOX1 (S1 E). This did however not correlate with neuronal differentia-
tion; instead there was a distinct failure to express the neuronal basic
helix–loop–helix (bHLH) transcription factor NEUROM (NEUROD4)
(S1 F) as well as the neuronal marker TUJ1 (S1 G). A similar pattern of
expression between spinal cord and cortex (Fig. 1A–F) prompted us to
overexpress Zac1 in E14.5mouse embryo cortices by in utero electropo-
ration. 24 h after electroporation, we observed a reduction of BrdU in-
corporation and KI67 immunoreactivity in cells overexpressing Zac1
(Fig. 1G–I and data not shown). There was however no signiﬁcant re-
duction in the number of SOX2 expressing cells after 24 h (Fig. 1J–L).
After 48 h the electroporated cortices exhibited a lower amount of
SOX2 expressing cells (S1 L–N). As in spinal cord, premature cell cycle
exit was not accompanied by an upregulation of markers for neuronal
differentiation. Rather therewas a signiﬁcant reduction of cells express-
ing the intermediate zone marker TBR2 in Zac1 electroporated cortices
both after 24 h (Fig. 1M–O) and 48 h (S1 O–Q). To ensure that lack of
TBR2 expression was not a consequence of precocious neuronal differ-
entiation, we performed immunostaining for TUJ1 but could not detect
any increase in the Zac1 electroporated cells (S1 H). Previous reports
has connected ZAC1 to apotosis (Spengler et al., 1997). We could how-
ever not detect any increased Caspase-3 immunoreactivity in the
electroporated cortices (data not shown). To determine if the reduced
number of BrdU incorporating cells in the Zac1 electroporated brains
was a consequence of an increased propensity for cell cycle exit, we per-
formed a BrdU pulse experiment. BrdUwas injected at E14.5, 24 h prior
to retrieval of the embryos and the cortical sections were stained for
BrdU andKI67 to calculate thenumber of electroporated cells remaining
in the cell cycle at E15.5. In the Zac1-Myc electroporated cortices there
was a signiﬁcant decrease in the ratio of electroporated cells that were
double positive for BrdU and KI67 compared to the eGFP electroporated
brains (Fig. 1P–R). Thus overexpression of Zac1 triggers premature cell
cycle exit and perturbs neuronal differentiation.
3.3. Genome wide analysis of Zac1 overexpression in neural progenitors
To understand the genomewide consequences of aberrant ZAC1
levels, we dissociated cortices into single cell suspension 24 h after elec-
troporation with pCAGG-Zac1 or pCAGG-eGFP and used FACS sorting to
obtain a pure population of cortical cells. RNA was extracted (3 Zac1
electroporated brains and 4 GFP control brains) and libraries were gen-
erated for RNA-seq analysis. Differential gene expression analysis
showed a signiﬁcant increase of 1116 genes and a decrease of 281
genes in the Zac1 overexpressing cells (Fig. 2A). The ZAC1 induced cell
cycle exit and stalled neuronal differentiation (Fig. 1H–R), was
mirrored by changes in gene expression: Even though expression levels
of early proneural bHLH factors Neurog1 and Neurog2 were unaltered,
several of their downstream factors, such as Neurod1, Neurod6, Dlx2
and Rnd3 exhibited decreased expression (Fig. 2A–B). In addition, an ex-
amination of raw RPKM (reads per kilobase of transcript per million
mapped reads) levels of the RNA-seq comparing control and Zac1
Fig. 1. ZAC1 is expressed in the cycling progenitors of thedevelopingCNS andpromotes cell cycle exit but not neuronal differentiation. (A–C) In E10.5 spinal cord ZAC1 immunoreactivity is
evident in BrdU+ (A) and SOX3+ (B) progenitors but not in TUJ1+ (C) cells in themarginal zone. (D–F) In E14.5 forebrain ZAC1 is expressed inBrdU+ cells (D) and in SOX3+ cells (E) of the
SVZ/VZ but not in TUJ1+ cells (F). (G–I) 24 h after electroporation, cells expressing Zac1-Myc in E15.5 forebrain exhibit lower levels of BrdU (H–I) incorporation compared to control (G, I).
(J–L) There is no reduction signiﬁcant in SOX2+ cells upon Zac1-Myc (J–L) expression. (M–O)Compared to control electroporated cells (M, O) signiﬁcantly fewer Zac1-Myc expressing cells
are TBR2+ (N–O). (P–R) A reduced cell cycle labeling index in Zac1-Myc expressing cells (Q–R) compared to control cells (P, R) indicate that an increased amount of Zac1-Myc cells have
exited the cell cycle 24 h after electroporation. In panels (H, K, N, Q) the overexpression of Zac1 is detected by a goat ZAC1 antibody that only detects ZAC1 upon overexpression. This is
denominated “ZAC1gt” to distinguish from staining of endogenous levels of ZAC1 by a rabbit antibody that in panels (A–F) is denominated as “ZAC1”, also see the experimental procedures
section. SC, spinal cord; CTX, cortex; LI, Labeling Index. Data are represented as mean ± SEM. **p b 0.01, ***p b 0.001, Student's t-test, n = 3–7. Scale bars, in C 80 μm; F 40 μm; N 20 μm.
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Map2 and Tubb3 (0.56× and 0.65×). Premature cell cycle exit (see
above) provoked by high levels of ZAC1 was mirrored by reduced
expression of positive regulators of cell cycle progression, among
themMycn, Ccnf and Cxcl12 (Fig. 2A–B).
ZAC1's role as a member of an IGN regulating embryonic growth
(Varrault et al., 2006) was vindicated by the augmented expression of
a cohort of imprinted target genes belonging to the IGN, including Igf2,
H19, Dlk1, Gnas and Igf2as in Zac1 overexpressing cells (Fig. 2B). There
was also an increased expression of the imprinted CKI Cdkn1c, encoding
for the P57 protein (Fig. 2A–B). A recent in vitro study suggested that
Zac1 induces cell cycle arrest through upregulation of Tcf4 expression
(Schmidt-Edelkraut et al., 2014). We could however not detect any
signiﬁcant change in the levels of Tcf4 in the electroporated cortical
cells neither with RNA-seq (data not shown) nor with qPCR (S4 M).
3.4. Elevated levels of ZAC1 promote expression of mesodermal/myogenic
factors and partial differentiation of neuronal progenitors into muscle
A previously reported comparison between different published data
sets showed that co-expression of imprinted genes is most frequent in
developing and regenerating muscle (Varrault et al., 2006). Indeed, Zac1
expression levels are high in proliferating cells of the dermomyotome
(Valente et al., 2005). Our analysis of the sequencing data revealed an en-
richment of mesodermal and muscle-associated gene ontology (GO)
terms (Fig. 2C) upon Zac1 overexpression. In addition there was a highly
signiﬁcant induction of bona ﬁde determinants of early mesoderm/
endoderm formation (Tbx6) (Takemoto et al., 2011) and myogenic fate/
differentiation (Myod1 andMyog). This was accompanied by increasedexpression ofWnt4 andWnt6 both ofwhich play key roles during somitic
myogenesis (vonMaltzahn et al., 2012), aswell asDesmin andMyoz1 that
encode for structural proteins of muscle ﬁbers (Granger & Lazarides,
1979; Faulkner et al., 2000) (Fig. 2D). Several other muscle-associated
factors were also signiﬁcantly upregulated upon Zac1 overexpression
(S2 A). We could also detect high levels of DESMIN protein organized in
a ﬁber-like fashion in electroporated cortices (Fig. 2E–F) revealing that
ZAC1promoted aspects ofmuscle differentiation at the expense of neuro-
nal differentiation. This effectwas evident even in the electroporated cells
that exhibited low to intermediate levels of Zac1 expression (Fig. 2F). To
understand if it is possible to provoke expression ofmuscle speciﬁc genes
in other types of neuronal progenitors we overexpressed Zac1 in the
human neuroblastoma cell line SH-SY5Y and in the mouse neuroblasto-
ma cell line Neuro2a. In both cell lines high levels of DESMIN protein
were visible upon Zac1 overexpression (S3 A–L). In contrast to the distri-
bution of DESMIN inﬁber like bundles detected in the electroporated cor-
tices (Fig 2F) the DESMIN protein exhibited a mainly nuclear localization
in the transfected neuroblastoma cells (S3 E, K). This could potentially be
a consequence of a lack of positional cues, or alternatively a less complete
reprogramming in the in vitro situation.
3.5. Aberrant levels of ZAC1 induce expression of pluripotency associated
genes
The most highly enriched GO category in Zac1 electroporated cells
was “mesenchymal to epithelial transition” (Fig. 2C) a category that
has been shown to be associated with groundstate pluripotency and in-
duction of pluripotency during iPSC formation (Wang et al., 2010). Fur-
thermore, an inducer of mesenchymal to epithelial transition, Foxh1
Fig. 2.Genomewide analysis of Zac1overexpression inneural progenitors (A)Volcanoplot showing signiﬁcantly up- vs. downregulated genes 24h after Zac1-Myc electroporation in E14.5
cortices. Plotted in red aremembers of the IGN, in blue neuronal genes and in green cell cycle genes. (B) Examples of the increase in IGN gene expression (red staples) and the decrease in
neuronal gene (blue staples) and cell cycle gene (green staples) expression. (C) Gene ontology analysis of 200 transcripts exhibiting the highest increase in expression upon Zac1-Myc
overexpression. (D) Expression levels of factors involved in mesoderm formation and muscle differentiation, signiﬁcantly increased upon Zac1-Myc electroporation. (E–F) Zac1-Myc ex-
pressing cells but not control electroporated cells exhibit robust levels of themuscle speciﬁc ﬁlament protein DESMIN (arrows in F). In electroporated cells with low-intermediate levels of
ZAC1 there was also an induction of DESMIN after 24 h (arrowheads in F). In the non electroporated part of the tissue (left of the dashed white line), no DESMIN immunoreactivity was
detected. (G) Levels of genes associated with pluripotency are upregulated in Zac1-Myc expressing cells, whereas factors acting as barriers for iPS reprogramming are downregulated.
(H) Venn diagram analysis of the Zac1-Myc expressing cells where there is a more than fourfold enrichment of factors previously identiﬁed as upregulated more than 20× upon Glis1
aided induction of pluripotency (Maekawa et al., 2011). (I–L) Compared to control electroporated cortices (I–J) there is robust alkaline phosphatase (AP) activity in the Zac1-Myc
electroporated cortices (K–L) 24 h after electroporation. *p b 0.05, **p b 0.01, ***p b 0.001, adjusted p-values calculated by Deseq2, n = 4 eGFP electroporated cortices and 3 Zac1
electroporated cortices. Scale bar, in F 20 μm; in L 40 μm.
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electroporated cells (Fig. 2G). FOXH1 has also recently been identiﬁed
as one of several determinants of endodermal andmesodermal lineages
that can facilitate iPSC formation or even substitute for some of the clas-
sical iPSC factors OCT4, SOX2, KLF4 and MYC (OSKM) (Takahashi et al.,
2014; Shu et al., 2013; Montserrat et al., 2013). Another example is
Glis1 (Maekawa et al., 2011), which was upregulated in the Zac1
electroporated cells (Fig. 2G). In the studywherein GLIS1was identiﬁed
as a facilitator of iPSC formation, microarray analysis showed that a co-
hort of 90 genes was increasedmore than twenty-fold in comparison to
iPSCs formed with only OSK (Maekawa et al., 2011). We observed a
more than four-fold enrichment of these genes in cells overexpressing
Zac1 (Fig. 2H). Expression of Esrrb, Sall4 and Lin28a, which have beenshown to be vital parts of a transcriptional hierarchy governing
pluripotency (Buganim et al., 2012; Percharde et al., 2012), was signiﬁ-
cantly upregulated in Zac1 expressing cells (Fig. 2G). Expression levels
of the transcriptional regulator Etv5 recently shown to be required for
both entry into early intermediate state of reprogramming and genera-
tion of fully reprogrammed iPSCs (Lujan et al., 2015) were also in-
creased (Fig. 2G). Alkaline phosphatase (AP) activity is a commonly
used early marker for augmented “stemness”. This in combination
with increased levels of Alpl transcript (Fig. 2G) coding for the AP
enzyme prompted us to stain for AP activity in Zac1 electroporated cor-
tices. In comparison to control electroporated cortices and in conﬁrma-
tion of our gene expression data, therewas robust AP activity (Fig. 2I–L).
In addition there was a signiﬁcant downregulation of genes encoding
Fig. 3. In E14.5 cortex ZAC1 promotes cell cycle exit through induction of the cell cycle in-
hibitor P57. (A–B) In comparison to control cells Zac1-Myc electroporated cells exhibit
high levels of P57. (C) In vitro reporter assay showed that expression of Zac1 activates
the P57 luc-reporter construct more than eight fold compared to cells transfected with
control construct. (D–F) Combined electroporation of scrambled control construct with
Zac1-Myc does not block upregulation of P57 (D, F). Knockdown of Cdkn1c silences Zac1
induced Cdkn1c expression (E–F). (G–I) In Zac1-Myc/shCdkn1c co-electroporated cells
the proportion of BrdU+ cells is increased (H) compared to cells co-electroporated with
scrambled control (G), quantiﬁed in (I). (J–L) There is no signiﬁcant change in TBR2 levels
between Zac1-Myc electroporated cells that are co-electroporatedwith scrambled control
or shCdkn1c, quantiﬁed in (L). (M–O) There is no signiﬁcant change in DESMIN levels be-
tween Zac1-Myc electroporated cells that are co-electroporatedwith scrambled control or
shCdkn1c, quantiﬁed in (O). Data are represented as mean ± SEM. *p b 0.05, ***p b 0.001,
Student's t-test, n = 3–8. Scale bar, in N 20 μm.
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H3K9me3 methyltransferase SETDB1 (Fig. 2G), all of which have been
shown to act as barriers for acquisition of pluripotency (Zhao et al.,
2008; Sridharan et al., 2013; Gaspar-Maia et al., 2013; Souﬁ et al.,
2012; Pasque et al., 2012). Thus, upon Zac1 overexpression there is
both a rapid upregulation of factors known to facilitate or be associated
with pluripotency and a reduction of factors impeding iPSC formation.
3.6. Elevated ZAC1 levels in an alternative model of neuronal differentiation
also induce reprogramming events
To validate our RNA-seq analysis we ﬁrst performed qPCR on ampli-
ﬁed cDNA from electroporated cortical cells for a subset of the genes
displaying altered expression levels. There was a good correlation of
both increases and decreases in expression levels between qPCR
and RNA-seq analysis (S4 A–M). To further investigate the capacity of
ZAC1 to promote reprogramming, we analyzed Zac1 transfected
mouse Neuro2A cells, an alternative model of neuronal differentiation,
using primers for several genes altered in the electroporated cortices ac-
cording to the RNA-seq. This analysis showed that imprinted genes
(Cdkn1c, Igf2), cell cycle genes (Ccnf), neuronal genes (Klf7, Tubb3,
Map2), mesodermal/muscle genes (Tbx6, Myog, Des) and pluripotency
associated genes (Foxh1, Glis1, Alpl) exhibited a similar pattern of regu-
lation as in the Zac1 electroporated cortices (S3M–X). This, in combina-
tionwith the clear induction of DESMIN protein in both human SH-S-5Y
cells (S3 A–F) and mouse Neuro2a cells (S3 G–L) support the ability of
elevated ZAC1 levels to induce reprogramming-like events in additional
models of neuronal differentiation.
3.7. ZAC1 induced cell cycle exit is dependent on induction of CKI expression
The increased expression of Cdkn1c upon Zac1 overexpression
(Fig. 2B) and a previous report of an in vitro model of neurogenesis
ZAC1 promoted cell cycle exit through induction of the CKI factor P57
encoded by the Cdkn1c gene (Schmidt-Edelkraut et al., 2014) prompted
us to perform immunoﬂuorescent staining with a P57 speciﬁc antibody.
In developing spinal cord there was no induction of P57 but there was
an increase in expression of the related CKI, Cdkn1b (S5 A) encoding for
the P27 protein. In electroporated cortices, however, there was a pro-
nounced induction of P57 (Fig. 3A–B). This effect was evident already
12 h after electroporation (S5 B). To understand if ZAC1 directly could ac-
tivate expression of Cdkn1c, we performed a reporter assay in HEK293
cells transfectedwith a Luciferase (Luc) reporter containing a 1025 bpup-
stream region of Cdkn1c. Indeed, Zac1 transfection signiﬁcantly activated
the Luc reporter (Fig. 3C). To elucidate whether ZAC1 induced
cell cycle exit is dependent on the upregulation of Cdkn1c expression
we co-electroporated pCAGG-Zac1 with a shRNA construct targeting
Cdkn1c or a scrambled control construct. In pCAGG-Zac1/shCdkn1c co-
electroporated cells there was a reduction in P57 immunoreactivity
(Fig. 3D–F) accompanied by restoration of a close to normal pattern of
BrdU incorporation (Fig. 3G–I). In contrast, knockdown of Cdkn1c in
Zac1 overexpressing cells could not rescue the failure to express TBR2
(Fig. 3J–L). Upregulation of themuscleﬁlamentDESMIN is likewise not af-
fectedby the knockdownofCdkn1c (Fig. 3M–O). In sum, this suggests that
stalled neuronal differentiation and induction of non-neuronal genes
caused by high levels of ZAC1 are separate events from the premature
cell cycle exit and less likely to be caused by increased P57 levels.
3.8. SOXB1 transcription factors bind to the Zac1 locus and negatively
regulate Zac1 expression
SOXB1 transcription factors are instrumental in the maintenance of
progenitor properties and in the control of neuronal differentiation
(Bylund et al., 2003). The expression of Zac1 and Soxb1 in the same cel-
lular compartment in combination with disrupted neurogenesis upon
Zac1-Myc expression suggested that SOXB1 proteins might regulateZac1 expression. In line with this possibility SOXB1 factors bind to a
conserved motif, TTTGT (Hagey & Muhr, 2014), present in the Zac1
locus (Fig. 4A). To understand if SOXB1 transcription factors can
Fig. 4. SOXB1 transcription factors bind to the Zac1 gene locus and controls its expression levels. (A) Chromatin immunoprecipitation with a SOX2 antibody reveals a binding peak in the
Zac1 gene locus, overlapping with a conserved SOXB1 binding motif. (B) Upon overexpression of Sox2 in the E13.5 cortex levels of the Zac1 transcript are decreased whereas when the
three SoxB1 transcription factors (Sox1-3) are simultaneously knockeddown there is an increase of Zac1 expression. (C) 95 Single E11.5 cortical cells divided into bins and ranked according
to their individual Sox2 expression levels (red bars). As Sox2 expression levels drop the Zac1 levels (green bars) increase. The expression levels (in RPKMs)were normalized to the average
level of each gene with the mean value set to 1. (D) In vitro reporter assay showed that expression of Sox2 at two different concentrations signiﬁcantly represses the Zac1 luc-reporter
construct whereas upon expression of a dominant negative version of SOX2 (dnSoxB1) there is an increase in Luc activity. H, human; M, mouse; C, chicken; Data are represented as
mean ± SEM. *p b 0.05, **p b 0.01, ***p b 0.001, Student's t-test.
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immunoprecipitation of E11.5 mouse cortices followed by deep
sequencing (ChIP-Seq) (Hagey &Muhr, 2014). Binding of SOX2was ap-
parent in the region containing the TTTGTmotif (Fig. 4A). To investigate
whether SOX2 may be involved in regulating Zac1 expression levels we
next analyzed data from in utero electroporated E13.5 cortical cells ei-
ther overexpressing Sox2 or shRNAs targeting Sox1-3 (Hagey & Muhr,
2014). Overexpression of Sox2 caused a reduction of Zac1 expression
levels relative to cells electroporated with a control construct, whereas
knockdown of Sox1-3 expression resulted in an increase in Zac1 levels
(Fig. 4B). Interestingly, despite that both Sox2 and Zac1 are expressed
in the germinal zone, analysis of a RNA-seq dataset based on single
cells obtained from E11.5mouse cortex (Hagey &Muhr, 2014) revealed
an inverse correlation between Sox2 and Zac1 expression levels
(Fig. 4C). Thus, cells with the highest levels of Sox2 expressed low levels
of Zac1, whereas cells with intermediate to low Sox2 levels displayed ro-
bust Zac1 expression levels (Fig. 4C). To investigate whether SOX2 has
the capacity to regulate Zac1 expression in a more direct manner we
performed a luciferase assay, on the regulatory region bound by SOX2,
wherein we could detect a signiﬁcant decrease of luciferase activity of
a Zac1-reporter construct upon Sox2 expression (Fig. 4D). Upon trans-
fection of a dominant negative version of SOX2 (dnSoxB1), that blocks
translocation of endogenous SOX2 to the nucleus (Hagey & Muhr,
2014), there was a signiﬁcant increase of Luc activity (Fig. 4D). In addi-
tion, immunostaining of embryonic stem (ES) cell derived neuronal
progenitors revealed that even though SOX2 and ZAC1 were present
in the same cells, we noted an inverse correlation between protein
levels of SOX2 and ZAC1; cells with high levels of SOX2 exhibited low
levels of ZAC1 and vice versa (S5 C–G). Taken together, our analysis sug-
gests that SOXB1 transcription factors serve to modulate levels of Zac1
expression in neural progenitors.4. Discussion
Here we report that elevated in vivo levels of the imprinted
transcription factor ZAC1 promote cell cycle exit, disrupt neurogenesis
and provoke a partial switch from neural to mesodermal/myogenic
lineage with additional expression of genes regulating pluripotency. In
contrast to other examples of de- or transdifferentiation, these events
occur in conjunction with cessation of proliferation and within less
than 24 h post electroporation. The expression of Zac1 has previously
been shown to be regulated by imprinting. We reveal an additional
mode of control through which SOX1B transcription factors negatively
modulate Zac1 levels. Furthermore, we show that the capacity of ZAC1
to promote cell cycle exit is dependent on P57 expression in the brain
and P27 in the spinal cord. However, disruption of neurogenesis and
expression of muscle speciﬁc markers seem less dependent on the
upregulation of P57.
Several studies have demonstrated howmisexpression of regulators
of alternative lineages can induce reprogramming (Holmberg &
Perlmann, 2012). In contrast, our study suggests that increased expres-
sion of an already highly expressed single gene can rapidly (b24 h) ini-
tiate in vivo reprogramming events that derail normal development.
This effect is more reminiscent of certain heterokaryon experiments
that also promote a rapid change in global gene expression and cellular
phenotype in cells that are not proliferative (Yamanaka & Blau, 2010).
ZAC1-induced reprogramming has a strong component of a switch
from neuroectodermal to mesodermal lineage followed by myogenic
differentiation, but also expression of endodermal lineage determinants
is induced (data not shown). Acquisition of features characteristic of
pluripotent cells could be a consequence of the expression of these
mesodermal and endodermal factors. Interestingly, recent studies have
introduced the “seesaw” model to explain how transcription factors
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replace some of the “classical” iPS factors (Shu et al., 2013; Loh &
Lim, 2011). As neuronal progenitors already express the
reprogramming factor Sox2, it is possible that the barrier to
reprogramming in these cells may already be lower, a phenomenon
previously shown to occur in adult neural stem cells (Kim et al.,
2009). However, Zac1 overexpression did not induce substantial
levels of Pou5f1 or Nanog. One possibility is that the rapid exit of
cell cycle in combination with myogenic-like differentiation acts a
barrier to the acquisition of full pluripotency.
The negative regulation of Zac1 expression by SOXB1 transcription
factors combined with the decrease of Sox2 expression as the levels of
Zac1 increase suggest that ZAC1 and SOXB1 factors could act as a
cross-repressive genetic switch governing the acquisition of distinct cel-
lular identities (Enver et al., 2009). However, our sequencing data show
nodecrease neither in Sox1, Sox2nor Sox3 expression upon Zac1 overex-
pression. Furthermore, expression of both Zac1 and SoxB1 factors pre-
cede the sequential generation of cells within the same lineage, which
is why it is hard to envisage how such a switch would work in this par-
ticular cellular setting. It is thus a rather different situation compared to
the hematopoietic system where there exist clear cell fate bifurcations
that are resolved by cross repressive transcription factors, e.g. in mye-
loid progenitors where the mutually repressive GATA-1 and PU.1 tran-
scription factors and additional co-factors promote either an erythroid
or a myeloid identity (Laiosa et al., 2006; Chickarmane et al., 2009).
Our data rather imply that expression levels of Zac1 are restricted by
SOXB1 factors to avoid aberrant induction of non-neuronal genes and
premature cell cycle exit. However the repression is rather modest
allowing Zac1 to be expressed at levels sufﬁcient for its endogenous
function. A recent study supports that expression levels of Zac1 need
to be precisely regulated as elevated levels promote cell cycle exit, dis-
rupt neuronal differentiation andmigrationwhile loss of or lower levels
of Zac1 expression affect neuronalmigration (Adnani et al., 2015). Inter-
estingly, we show that elevated levels of ZAC1 result in a distinct upreg-
ulation of Tbx6, a gene that has been shown to cross-repress Sox2 in
order to promote the acquisition of a mesendodermal cell fate and to
block the neuroectodermal fate promoted by SOX2 (Takemoto et al.,
2011). Thus, elevated ZAC1 levels in cortical progenitors trigger in-
creased levels of non-neuronal lineage determinants (e.g. Tbx6, Myog,
Myod1 and Foxh1) which rapidly tilt cellular fate towards the mesoder-
mal and endodermal lineages at the expense of neuronal identity.
Recent studies have muddled the distinction between lineage
determinants and pluripotency factors and even suggested that
pluripotency is the result of balance between determinants of different
lineages. Thus, in cells with elevated levels of ZAC1 the apparent acqui-
sition of pluripotency features could be a consequence of a balance
between induced transcription factors governing the acquisition of
non-neuronal lineages and the endogenous high levels of neural
determinants (e.g. SOX1-3 and PAX6). Interestingly, several of the re-
cently discovered non-classical iPS factors not only have the capacity
to substitute classical iPS factors but also improve both efﬁciency
(Takahashi et al., 2014;Maekawa et al., 2011) of the process and quality
(Buganim et al., 2014) of the iPSCs formed. Indeed, several of the factors
(Foxh1, Glis1, Sall4, Esrrb and Lin28a) upregulated by Zac1 overexpres-
sion belong to this category implying that Zac1 could be an interesting
candidate for possible improvement of iPSC formation. Such an effort
would have to overcome the cell cycle exit induced by high levels of
ZAC1 as well as the propensity of these cells to differentiate into muscle
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